Patents by Inventor Bruno Buisson

Bruno Buisson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9320745
    Abstract: The present invention relates to the use of cholest-4-en-3-one derivatives for obtaining a cytoprotective drug, with the exception of a neuroprotective drug.
    Type: Grant
    Filed: March 28, 2007
    Date of Patent: April 26, 2016
    Assignee: TROPHOS
    Inventors: Rebecca Pruss, Bruno Buisson, Thierry Bordet
  • Patent number: 8575138
    Abstract: A method for providing neuroprotection to a patient in need of neuroprotection, comprising administering a neuroprotective-effective amount of a compound of formula I in which X is an oxygen atom or an ?N—OH group, R is selected from the group consisting of A is a hydrogen atom or together with B a carbon-carbon bond, B is a hydrogen atom, a hydroxy group or together with A a carbon-carbon bond, C is a hydrogen atom or together with D a carbon-carbon bond, D is a hydrogen atom or together with C a carbon-carbon bond, E is a hydrogen atom or together with F a carbon-carbon bond, F is a hydrogen atom or together with E a carbon-carbon bond, or an addition salt with a pharmaceutically acceptable acid.
    Type: Grant
    Filed: August 22, 2012
    Date of Patent: November 5, 2013
    Assignee: Trophos
    Inventors: Thierry Bordet, Cyrille Drouot, Bruno Buisson
  • Patent number: 8354395
    Abstract: A method for providing neuroprotection to a patient in need of neuroprotection, comprising administering a neuroprotective-effective amount of a compound of formula I in which X is an oxygen atom or an ?N—OH group, R is selected from the group consisting of A is a hydrogen atom or together with B a carbon-carbon bond, B is a hydrogen atom, a hydroxy group or together with A a carbon-carbon bond, C is a hydrogen atom or together with D a carbon-carbon bond, D is a hydrogen atom or together with C a carbon-carbon bond, E is a hydrogen atom or together with F a carbon-carbon bond, F is a hydrogen atom or together with E a carbon-carbon bond, or an addition salt with a pharmaceutically acceptable acid.
    Type: Grant
    Filed: August 22, 2012
    Date of Patent: January 15, 2013
    Assignee: Trophos
    Inventors: Thierry Bordet, Cyrille Drouot, Bruno Buisson
  • Publication number: 20120316141
    Abstract: A method for providing neuroprotection to a patient in need of neuroprotection, comprising administering a neuroprotective-effective amount of a compound of formula I in which X is an oxygen atom or an ?N—OH group, R is selected from the group consisting of A is a hydrogen atom or together with B a carbon-carbon bond, B is a hydrogen atom, a hydroxy group or together with A a carbon-carbon bond, C is a hydrogen atom or together with D a carbon-carbon bond, D is a hydrogen atom or together with C a carbon-carbon bond, E is a hydrogen atom or together with F a carbon-carbon bond, F is a hydrogen atom or together with E a carbon-carbon bond, or an addition salt with a pharmaceutically acceptable acid.
    Type: Application
    Filed: August 22, 2012
    Publication date: December 13, 2012
    Applicant: TROPHOS
    Inventors: Thierry BORDET, Cyrille DROUOT, Bruno BUISSON
  • Publication number: 20120309721
    Abstract: A method for providing neuroprotection to a patient in need of neuroprotection, comprising administering a neuroprotective-effective amount of a compound of formula I in which X is an oxygen atom or an =N—OH group, R is selected from the group consisting of A is a hydrogen atom or together with B a carbon-carbon bond, B is a hydrogen atom, a hydroxy group or together with A a carbon-carbon bond, C is a hydrogen atom or together with D a carbon-carbon bond, D is a hydrogen atom or together with C a carbon-carbon bond, E is a hydrogen atom or together with F a carbon-carbon bond, F is a hydrogen atom or together with E a carbon-carbon bond, or an addition salt with a pharmaceutically acceptable acid.
    Type: Application
    Filed: August 22, 2012
    Publication date: December 6, 2012
    Applicant: TROPHOS
    Inventors: Thierry Bordet, Cyrille Drouot, Bruno Buisson
  • Patent number: 8283341
    Abstract: A method for providing neuroprotection to a patient in need of neuroprotection, comprising administering a neuroprotective-effective amount of a compound of formula I in which X is an oxygen atom or an ?N—OH group, R is selected from the group consisting of A is a hydrogen atom or together with B a carbon-carbon bond, B is a hydrogen atom, a hydroxy group or together with A a carbon-carbon bond, C is a hydrogen atom or together with D a carbon-carbon bond, D is a hydrogen atom or together with C a carbon-carbon bond, E is a hydrogen atom or together with F a carbon-carbon bond, F is a hydrogen atom or together with E a carbon-carbon bond, or an addition salt with a pharmaceutically acceptable acid.
    Type: Grant
    Filed: May 7, 2010
    Date of Patent: October 9, 2012
    Assignee: Trophos
    Inventors: Thierry Bordet, Cyrille Drouot, Bruno Buisson
  • Patent number: 7985774
    Abstract: The present invention relates to the use of 3,5-seco-4-nor-cholestane derivatives for obtaining a cytoprotective drug, with the exception of a neuroprotective drug, notably a cardioprotective or hepatoprotective drug.
    Type: Grant
    Filed: February 23, 2007
    Date of Patent: July 26, 2011
    Assignee: Trophos
    Inventors: Rebecca Pruss, Bruno Buisson, Thierry Bordet
  • Patent number: 7858603
    Abstract: Compound of formula I where X=O or ?N—OH group, R represents a group chosen from A=hydrogen or together with B a carbon-carbon bond, B=hydrogen, hydroxy or together with A a carbon-carbon bond, C, D, E, F=hydrogen or together with D a carbon-carbon bond, or the one of its addition salts with pharmaceutically acceptable acids, with the exception of a few compounds, as a medicament, use in particular as neuroprotectors, novel compounds of formula I and pharmaceutical compositions.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: December 28, 2010
    Assignee: TROPHOS
    Inventors: Thierry Bordet, Cyrille Drouot, Bruno Buisson
  • Publication number: 20100216752
    Abstract: A method for providing neuroprotection to a patient in need of neuroprotection, comprising administering a neuroprotective-effective amount of a compound of formula I in which X is an oxygen atom or an ?N—OH group, R is selected from the group consisting of A is a hydrogen atom or together with B a carbon-carbon bond, B is a hydrogen atom, a hydroxy group or together with A a carbon-carbon bond, C is a hydrogen atom or together with D a carbon-carbon bond, D is a hydrogen atom or together with C a carbon-carbon bond, E is a hydrogen atom or together with F a carbon-carbon bond, F is a hydrogen atom or together with E a carbon-carbon bond, or an addition salt with a pharmaceutically acceptable acid.
    Type: Application
    Filed: May 7, 2010
    Publication date: August 26, 2010
    Applicant: TROPHOS
    Inventors: Thierry BORDET, Cyrille Drouot, Bruno Buisson
  • Publication number: 20100171516
    Abstract: An apparatus includes a substrate plate (12), a set (16) of microelectrodes arranged on the upper face (14) of the substrate plate (12) and a tank (24) which is capable of containing living cells and an perfusion liquid, and which includes a vertical cylindrical lateral skirt (36) which is open towards the top and which surrounds an area including the set (16) of microelectrodes; characterized in that the lateral skirt (36) is attached in a sealed and detachable way with respect to the substrate plate (12).
    Type: Application
    Filed: August 6, 2007
    Publication date: July 8, 2010
    Applicant: NEUROSERVICE
    Inventors: Bruno Buisson, Ester-Marie Armougom-Steidl
  • Publication number: 20090312434
    Abstract: The present invention relates to the use of 3,5-seco-4-nor-cholestane derivatives for obtaining a cytoprotective drug, with the exception of a neuroprotective drug, notably a cardioprotective or hepatoprotective drug.
    Type: Application
    Filed: February 23, 2007
    Publication date: December 17, 2009
    Applicant: TROPHOS
    Inventors: Rebecca Pruss, Bruno Buisson, Thierry Bordet
  • Publication number: 20090186863
    Abstract: The present invention relates to the use of cholest-4-en-3-one derivatives for obtaining a cytoprotective drug, with the exception of a neuroprotective drug.
    Type: Application
    Filed: March 28, 2007
    Publication date: July 23, 2009
    Applicant: TROPHOS
    Inventors: Rebecca Pruss, Bruno Buisson, Thierry Bordet
  • Publication number: 20060217358
    Abstract: Compound of formula I where X=O or ?N—OH group, R represents a group chosen from A=hydrogen or together with B a carbon-carbon bond, B=hydrogen, hydroxy or together with A a carbon-carbon bond, C, D, E, F=hydrogen or together with D a carbon-carbon bond, or the one of its addition salts with pharmaceutically acceptable acids, with the exception of a few compounds, as a medicament, use in particular as neuroprotectors, novel compounds of formula I and pharmaceutical compositions.
    Type: Application
    Filed: March 5, 2004
    Publication date: September 28, 2006
    Applicant: TROPHOS
    Inventors: Thierry Bordet, Cyrille Drouot, Bruno Buisson